Mereo BioPharma Group plc
MREO
13 insider filings · Latest: Feb 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Sep 12 8:05 PM | Sermon Charles | Proposed Sale | 30,926 | $4.66 | $144.1K | — | View → |
| Sep 12, 2024 | Sep 12 8:05 PM | Alexandra Hughes-Wilson | Proposed Sale | 148,110 | $4.66 | $690.2K | — | View → |
| Sep 12, 2024 | Sep 12 8:05 PM | Lewicki John A. | Proposed Sale | 16,149 | $4.66 | $75.3K | — | View → |
| Sep 12, 2024 | Sep 12 8:05 PM | Scots-Knight Denise | Proposed Sale | 88,657 | $4.66 | $413.1K | — | View → |
| Sep 12, 2024 | Sep 12 8:05 PM | Fox Christine Ann | Proposed Sale | 28,286 | $4.66 | $131.8K | — | View → |
| Aug 22, 2024 | Aug 22 10:35 PM | Deepika Pakianathan | Proposed Sale | 105,244 | $4.43 | $466.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Feb 27 9:30 PM | Pierre JacquetDirector | Grant/Award | 172,848 | $0.39 | 106,848(D) | View → |
| Feb 26, 2026 | Feb 27 9:30 PM | Marc J YoskowitzDirector | Grant/Award | 162,163 | $0.39 | 96,163(D) | View → |
| Feb 26, 2026 | Feb 27 9:30 PM | Daniel ShamesDirector | Grant/Award | 162,163 | $0.39 | 96,163(D) | View → |
| Feb 26, 2026 | Feb 27 9:30 PM | Anders EkblomDirector | Grant/Award | 199,560 | $0.39 | 133,560(D) | View → |
| Feb 26, 2026 | Feb 27 9:30 PM | Jeremy BenderDirector | Grant/Award | 183,533 | $0.39 | 117,533(D) | View → |
| Feb 26, 2026 | Feb 27 9:30 PM | Deepika PakianathanDirector | Grant/Award | 66,000 | $0.39 | 66,000(D) | View → |
| Feb 26, 2026 | Feb 27 9:30 PM | Annalisa JenkinsDirector | Grant/Award | 172,848 | $0.39 | 106,848(D) | View → |
| Feb 26, 2026 | Feb 27 9:30 PM | Michael S WyzgaDirector | Grant/Award | 66,000 | $0.39 | 66,000(D) | View → |
| Feb 1, 2026 | Feb 2 9:30 PM | John A. LewickiChief Scientific Officer | Grant/Award | 331,550 | $1.00 | 145,000(D) | View → |
| Feb 1, 2026 | Feb 2 9:30 PM | Alexandra Hughes-WilsonChief Patient Access and Commercial Planning | Grant/Award | 440,000 | $1.00 | 195,000(D) | View → |
| Feb 1, 2026 | Feb 2 9:30 PM | Charles SermonGeneral Counsel | Grant/Award | 716,000 | $1.00 | 295,000(D) | View → |
| Feb 1, 2026 | Feb 2 9:30 PM | Denise Scots-KnightDirector, Chief Executive Officer | Grant/Award | 1,860,000 | $1.00 | 480,000(D) | View → |
| Feb 1, 2026 | Feb 2 9:30 PM | Christine Ann FoxChief Financial Officer | Grant/Award | 701,000 | $1.00 | 280,000(D) | View → |